Keywords: cv, thera, initiates, ranexa, study, therapeutics, initiated

CV Thera initiates Ranexa study

Article | 09 August 2004

Print This

CV Therapeutics has initiated an approval-enabling study of Ranexa(ranolazine) which, if successful, could support approval of the drug for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in